Kitov Pharma is a clinical-stage company focusing on advancing first in class therapies to overcome tumor immune evasion and drug resistance , to create successful long lasting treatment for people with cancer.
Word on the street is there is might be a possible buy out to by Merck & Co (MRK)
MRK filed an 8K SEC filing
Limited information on what the 8K SEC filing was for
Just got a approved for NT-219 drug
Estimated to be Worth close to a billion
Closed direct offering for 35.0 Million
Lots of momentum from 06/24/20 - may continue into Monday
This is not stock advice to buy, do your own dd
Comentários